These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 10346673

  • 1. The regulation of human tissue in the United States: a regulatory and legislative analysis.
    Williams MO.
    Food Drug Law J; 1997; 52(4):409-28. PubMed ID: 10346673
    [No Abstract] [Full Text] [Related]

  • 2. The commodification of human body parts: regulating the tissue bank industry.
    Zodrow JJ.
    Southwest Univ Law Rev; 2003; 32(3):407-49. PubMed ID: 15212024
    [No Abstract] [Full Text] [Related]

  • 3. Infections associated with musculoskeletal-tissue allografts.
    Polder JA, Wood JJ, Braun MM.
    N Engl J Med; 2004 Sep 23; 351(13):1358-60; author reply 1358-60. PubMed ID: 15390367
    [No Abstract] [Full Text] [Related]

  • 4. Practical issues in tissue banking.
    Haimowitz MD.
    Am J Clin Pathol; 1997 Apr 23; 107(4 Suppl 1):S75-81. PubMed ID: 9124234
    [Abstract] [Full Text] [Related]

  • 5. Human tissues and reproductive cloning: new technologies challenge FDA.
    Merrill RA.
    Houst J Health Law Policy; 2002 Apr 23; 3(1):1-82. PubMed ID: 15712415
    [No Abstract] [Full Text] [Related]

  • 6. Overview of FDA regulation of human cellular and tissue-based products.
    Wells MA.
    Food Drug Law J; 1997 Apr 23; 52(4):401-8. PubMed ID: 10346672
    [No Abstract] [Full Text] [Related]

  • 7. Tissue banking regulations and oversight.
    Eisenbrey AB, Frizzo W.
    Clin Lab Med; 2005 Sep 23; 25(3):487-98. PubMed ID: 16129189
    [No Abstract] [Full Text] [Related]

  • 8. Safeguarding human tissue transplants.
    Henkel J.
    FDA Consum; 1994 Sep 23; 28(7):9-13. PubMed ID: 10139008
    [Abstract] [Full Text] [Related]

  • 9. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Nov 24; 69(226):68611-88. PubMed ID: 15562555
    [Abstract] [Full Text] [Related]

  • 10. Skin and bones: post-mortem markets in human tissue.
    Charo RA.
    Nova Law Rev; 2002 Nov 24; 26(2):421-50. PubMed ID: 12627562
    [No Abstract] [Full Text] [Related]

  • 11. FDA regulation of human cloning: usurpation or statesmanship?
    Merrill RA, Rose BJ.
    Harv J Law Technol; 2001 Nov 24; 15(1):85-148. PubMed ID: 15156886
    [No Abstract] [Full Text] [Related]

  • 12. He's all heart . . . and a little pig too: a look at the FDA draft xenotransplant guideline.
    Fredrickson JK.
    Food Drug Law J; 1997 Nov 24; 52(4):429-51. PubMed ID: 10346674
    [No Abstract] [Full Text] [Related]

  • 13. The international harmonization of human tissue regulation: regulatory control over human tissue use and tissue banking in select countries and the current state of international harmonization efforts.
    Indech B.
    Food Drug Law J; 2000 Nov 24; 55(3):343-72. PubMed ID: 11824465
    [No Abstract] [Full Text] [Related]

  • 14. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL.
    Indiana Health Law Rev; 2005 Nov 24; 2(1):295-328. PubMed ID: 17111505
    [No Abstract] [Full Text] [Related]

  • 15. Trends and events in FDA regulation of medical devices over the last fifty years.
    Munsey RR.
    Food Drug Law J; 1995 Nov 24; 50 Spec():163-77. PubMed ID: 10343041
    [No Abstract] [Full Text] [Related]

  • 16. [Commentary on the article of A. Pruss and R. von Versen: Influence of European regulations on quality, safety and availability of cell and tissue allografts in Germany].
    Middeler G, Machens HG.
    Handchir Mikrochir Plast Chir; 2007 Apr 24; 39(2):88-90. PubMed ID: 17497602
    [No Abstract] [Full Text] [Related]

  • 17. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Jan 27; 69(17):3823-6. PubMed ID: 14968801
    [Abstract] [Full Text] [Related]

  • 18. [Influence of European regulations on quality, safety and availability of cell and tissue allografts in Germany].
    Pruss A, von Versen R.
    Handchir Mikrochir Plast Chir; 2007 Apr 27; 39(2):81-7. PubMed ID: 17497601
    [Abstract] [Full Text] [Related]

  • 19. Should human tissue transplants be regulated?
    Margolis RE.
    Healthspan; 1992 Dec 27; 9(11):17-9. PubMed ID: 10123553
    [No Abstract] [Full Text] [Related]

  • 20. Neurological devices; classification of human dura mater. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 18; 68(243):70435-6. PubMed ID: 14682309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.